Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Image of Woman measuring out a vaccine into a needle. Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DOD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DOD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DOD is only participating in the AstraZeneca study. Additional DOD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

We Can Do It (1081 x 1081)

Infographic
1/10/2022
We Can Do It  (1081 x 1081)

We can do it: Simple measures can protect you and your community. Wear a mask, get vaccinated, and check out where and when you can get your booster! https://tricare.mil/coronavirus

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

We Have the Tools

Infographic
1/10/2022
We Have the Tools

We have the tools to fight: Protect yourself and your community from the spread of COVID-19 with the right tools. Make sure you wear your mask, get vaccinated, and find your nearest testing site. Learn more https://tricare.mil/coronavirus

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

We Can Do It (1201 x 901)

Infographic
1/10/2022
We Can Do It  (1201 x 901)

We can do it: Simple measures can protect you and your community. Wear a mask, get vaccinated, and check out where and when you can get your booster! https://tricare.mil/coronavirus

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19

Vax Facts for Children

Infographic
11/4/2021
Vax Facts for Children

Should Young Children Get the COVID-19 Vaccine? Yes. The CDC recommends that children ages 5-11 receive the Pfizer-BioNTech COVID-19 pediatric vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Vaccines for Children

Vaccine for Children TLDR

Infographic
11/4/2021
Vaccine for Children TLDR

Vaccination is our best defense against the spread of COVID-19.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Vaccines for Children

Get to Know the Vaccines

Infographic
9/17/2021
Get to Know the Vaccines

A graphic showing the types of vaccines, how they work, and safety monitoring of the vaccines. Includes the MHS and TRICARE logos on the bottom right, and includes graphics of scientists, doctors, and patients.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

Get to know the COVID19 Vaccines

Infographic
9/17/2021
Get to know the COVID19 Vaccines

Get to know the vaccines - they do not contain the live virus, they do not interact with our DNA, and have been tested rigorously

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines

COVID-19 Booster Shots

Infographic
8/27/2021
COVID-19 Booster Shots

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Mask Guidance for Department of Defense Facilities

Infographic
7/30/2021
Mask Guidance for Department of Defense Facilities

In accordance with CDC guidance, the Department of Defense (DOD) requires all Service members, Federal employees, onsite contractor employees, and visitors, regardless of vaccination status, to wear a mask in all indoor DOD facilities. If you are not vaccinated, continue to physically distance consistent with applicable CDC and DOD Force Health Protection Guidance.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

COVID-19: Get Your Second Shot

Infographic
6/22/2021
COVID-19: Get Your Second Shot

You're not fully vaccinated - or protected - until two weeks after getting your second shot of the Pfizer or Moderna vaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts

How COVID-19 Vaccines Work

Infographic
6/9/2021
How COVID-19 Vaccines Work

This graphic showing how the mRNA and viral vector vaccines work to educate beneficiaries about the COVID-19 vaccines. Graphics are informational and provide facts on how they work in our bodies.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

COVID-19 Vaccines Safety Monitoring

Infographic
6/9/2021
COVID-19 Vaccines Safety Monitoring

Graphic that assures beneficiaries that the COVID-19 vaccines are monitored for safety. Has information on how they are being reviewed. Graphics include doctors in a laboratory and a doctor with a shield fending off the virus.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines - Main Infographic

Infographic
6/9/2021
Get to Know the COVID-19 Vaccines - Main Infographic

This infographic pulls all three COVID-19 topics together in one graphic: Getting to Know the COVID-19 Vaccines, How they Work and Safety Monitoring

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Get to Know the COVID-19 Vaccines | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Get to Know the COVID-19 Vaccines

Infographic
6/9/2021
Get to Know the COVID-19 Vaccines

This graphic that assures beneficiaries that the vaccines will not give you the virus, does not affect our DNA, and is safe. Graphics include a person receiving the vaccine and a comparison graphic of COVID-19 trials versus other trials.

Recommended Content:

Get to Know the COVID-19 Vaccines | Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

Facemask Required

Infographic
6/4/2021
Facemask Required

While the CDC relaxed mask requirements for vaccinated people, you're still required to wear masks in health care settings. Print this poster and put it around your facility to let patients and visitors know the requirements.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Prevent COVID-19
<< < 1 2 3 4 5  ... > >> 
Showing results 16 - 30 Page 2 of 6
Refine your search
Last Updated: August 09, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.